ClassID:

96357

C07H5/10 - CPC Classification

Classification description:

Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur

Recent Application in this class:
#1
20250092077
2025-03-20

DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF

#2
20250092076
2025-03-20

DITHIOLSACCHARIDE MUCOLYTIC AGENTS AND USES THEREOF

#3
20250059226
2025-02-20

Sulfinate glycosyl donor, method for preparing same, and use thereof

#4
20240287121
2024-08-29

GALECTIN-3 INHIBITING C-GLYCOSIDE OXIMES

#5
20240076553
2024-03-07

NONIONIC, REDOX-CLEAVABLE SURFACTANT FOR MASS SPECTROMETRY-BASED PROTEOMICS AND STRUCTURAL BIOLOGICAL APPLICATIONS

#6
20230382939
2023-11-30

MACROCYCLIC HOST MOLECULE-BASED CORE-SHELL NANOPARTICLES AND METHOD FOR SYNTHESIZING SAME

#7
20230140631
2023-05-04

TREATMENT OF METABOLIC DISORDERS IN FELINE ANIMALS

#8
20220363706
2022-11-17

5`S-LNA nucleotides and oligonucleotides

#9
20220227810
2022-07-21

Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

#10
20210230202
2021-07-29

Dithiolsaccharide mucolytic agents and uses thereof

#11
20210221836
2021-07-22

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#12
20210169110
2021-06-10

METHOD FOR EXTRACTING WASABI EXTRACT

#13
20210115082
2021-04-22

Glycoside compound and preparation method therefor, composition, application, and intermediate

#14
20210002388
2021-01-07

Method for preparation of derivatives of gram-positive bacteria surface capsular polysaccharide

#15
20200317708
2020-10-08

SUGAR-LINKED AMINO ACIDS FOR SOLID-PHASE PEPTIDE SYNTHESIS

#16
20200215099
2020-07-09

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#17
20200197352
2020-06-25

Treatment of metabolic disorders in feline animals

#18
20190375776
2019-12-12

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#19
20190292213
2019-09-26

5′S-LNA nucleotides and oligonucleotides

#20
20190125782
2019-05-02

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#21
20180256634
2018-09-13

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#22
20180251486
2018-09-06

Lincomycin biosynthetic intermediates, method for preparation, and use thereof

#23
20180179255
2018-06-28

Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

#24
20170360823
2017-12-21

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#25
20170275326
2017-09-28

IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS

#26
20170166691
2017-06-15

METAL CHALCOGENIDE NANOSTRUCTURES

#27
20170051003
2017-02-23

Reagent-controlled stereoselective glycosylation

#28
20160355497
2016-12-08

Thiopyranose compound and method for producing same

#29
20160237105
2016-08-18

Ruthenium carbon monoxide releasing molecules and uses thereof

#30
20160136267
2016-05-19

Sphingoglycolipid analogues

#31
20160096861
2016-04-07

Galactoside inhibitor of galectins

#32
20150322105
2015-11-12

RUTHENIUM CARBON MONOXIDE RELEASING MOLECULES AND USES THEREOF

#33
20150284419
2015-10-08

METHOD FOR PREPARING FULLY PROTECTION HEPARIN PENTASACCHARIDE AND INTERMEDIATE THEREOF

#34
20150274764
2015-10-01

Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis

#35
20150038689
2015-02-05

Reagent controlled stereoselective glycosylation

#36
20150018537
2015-01-15

Process for perparing fondaparinux sodium and intermediates useful in the synthesis thereof

#37
20140323422
2014-10-30

Anionic conjugates of glycosylated bacterial metabolite

#38
20140171630
2014-06-19

NOVEL SYNTHESIS OF GALACTOSIDE INHIBITORS

#39
20140121180
2014-05-01

Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical cosmetic uses of same

#40
20130209444
2013-08-15

NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES

#41
20120302519
2012-11-29

Multiple substituted fluoromethanes as selective and bioactive isosteres

#42
20120264702
2012-10-18

Synthesis and use of glycoside derivatives of propofol

#43
20110236312
2011-09-29

NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS

#44
20110190233
2011-08-04

Anionic conjugates of glycosylated bacterial metabolite

#45
20110130553
2011-06-02

Synthesis of galactoside inhibitors

#46
20110105418
2011-05-05

Process for preparing Fondaparinux sodium and intermediates useful in the synthesis thereof

#47
20100304445
2010-12-02

NUCLEIC ACID PACKAGING SYSTEM

#48
20090227532
2009-09-10

Analogues of coformycin and their use for treating protozoan parasite infections

#49
20090176970
2009-07-09

Preparation of Thiosugars and Their Use

#50
20090176717
2009-07-09

GALACTOSIDES AND THIODIGALACTOSIDES AS INHIBITORS OF PA-IL LECTIN FROM PSEUDOMONAS

#51
20080193389
2008-08-14

Use of glycodendrimer reagents for inhibiting adhesion by microorganisms

#52
20070219144
2007-09-20

IMMUNOMODULATORY SACCHARIDE COMPOUNDS

#53
20070213506
2007-09-13

Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins

#54
20060205931
2006-09-14

Pharmaceutical compositions having appetite suppressant activity

#55
20060014702
2006-01-19

Antimicrobial agent

#56
20050272670
2005-12-08

Synthesis and use of glycodendrimer reagents

#57
20050256143
2005-11-17

Purine nucleosides

#58
20050049221
2005-03-03

Food or beverage containing fucoidan and method of production thereof

#59
20050009765
2005-01-13

Heterodimeric conjugates of neomycin-chloramphenicol having an enhanced specificity against RNA targets and its preparation

#60
16035625
2019-10-08

Alpha-selective sialyl donor and its uses for preparation of sialosides